A Review of the Components of Seaweeds as Potential Candidates in Cancer Therapy

Anticancer Agents Med Chem. 2018;18(3):354-366. doi: 10.2174/1871520617666171106130325.

Abstract

The marine natural products (MNPs) isolated from seaweeds-associated microbial communities have received substantial attention owing to their exceptional nutritional and pharmacology application, such as antiviral, anticancer, antiprotozoal, antifungal, and antibacterial properties and so on. Particularly, there are several MNPs that have been displayed attractive value for the development of novel anticancer agents. This review covers the literature published in the recent 5 years on the novel anticancer MNPs discovered originating from seaweeds, and focused on the chemistry and relative anticancer activities of new MNPs which categorize their source organisms. These seaweed-derived MNPs are categorized based on their origin as brown algae, red algae, cyanobacteria, chlorophyta and others.

Keywords: MNPs; Seaweeds; anticancer; brown algae; chlorophyta; cyanobacteria; red algae..

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Biological Products / chemistry
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Humans
  • Neoplasms / drug therapy*
  • Seaweed / chemistry*

Substances

  • Antineoplastic Agents
  • Biological Products